REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · IEX Real-Time Price · USD
12.58
-0.27 (-2.10%)
At close: Jul 19, 2024, 4:00 PM
12.63
+0.05 (0.40%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
REGENXBIO Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for REGENXBIO stock have an average target of 40.5, with a low estimate of 21 and a high estimate of 55. The average target predicts an increase of 221.94% from the current stock price of 12.58.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 20, 2024.
Analyst Ratings
The average analyst rating for REGENXBIO stock from 11 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 4 | 4 |
| Buy | 3 | 6 | 6 | 6 | 6 | 6 |
| Hold | 2 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 10 | 10 | 10 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +202.07% | Jun 20, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $38 | Strong Buy | Initiates | $38 | +202.07% | Jun 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $36 → $38 | Strong Buy | Maintains | $36 → $38 | +202.07% | May 15, 2024 |
| Stifel | Stifel | Strong Buy Maintains $40 | Strong Buy | Maintains | $40 | +217.97% | Apr 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $36 | Strong Buy | Initiates | $36 | +186.17% | Mar 11, 2024 |
Financial Forecast
Revenue This Year
110.63M
from 90.24M
Increased by 22.59%
Revenue Next Year
287.71M
from 110.63M
Increased by 160.07%
EPS This Year
-5.14
from -6.02
EPS Next Year
-2.52
from -5.14
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 166.2M | 452.6M | 396.0M | 562.7M | 790.9M |
| Avg | 110.6M | 287.7M | 274.8M | 451.9M | 592.2M |
| Low | 62.4M | 79.0M | 175.9M | 315.9M | 499.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 84.1% | 309.1% | 37.6% | 104.8% | 75.0% |
| Avg | 22.6% | 160.1% | -4.5% | 64.5% | 31.0% |
| Low | -30.9% | -28.6% | -38.9% | 15.0% | 10.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -4.68 | 0.13 | -1.38 | -0.76 | 0.95 |
| Avg | -5.14 | -2.52 | -2.57 | -1.13 | 0.90 |
| Low | -5.50 | -5.38 | -4.24 | -1.46 | 0.84 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.